SCHEMBL19934847

SCHEMBL19934847

COc1cc(C#N)c(I)c(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.44
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
IMPDH2 P12268 1/20 0.38
IMPDH1 P20839 1/20 0.38
SRC P12931 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
MAPT P10636 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929841 0.81 AR (0.44) ARALDH1A1KDM4EUSP2IMPDH2
SCHEMBL504691 0.79 ALDH1A1 (0.53) ALDH1A1KDM4EUSP2CA12CA1
SCHEMBL4694671 0.78 AR (0.49) ARALDH1A1KDM4EUSP2POLB
SCHEMBL4406542 0.78 AR (0.45) ARALDH1A1KDM4EUSP2POLB
SCHEMBL18484464 0.78 SRC (0.47) ARALDH1A1KDM4EUSP2POLB
SCHEMBL4053443 0.77 AR (0.44) ARALDH1A1KDM4EUSP2POLB
SCHEMBL5787995 0.77 AR (0.44) ARALDH1A1KDM4EUSP2POLB
SCHEMBL4053444 0.77 ALDH1A1 (0.50) ARALDH1A1KDM4EUSP2POLB
SCHEMBL13748281 0.74 AR (0.41) ARALDH1A1KDM4EUSP2POLB
SCHEMBL2547123 0.73 ALDH1A1 (0.50) ARALDH1A1KDM4EUSP2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-12-17 US disclosed
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 AR 3875/4885ALDH1A1 2161/4885KDM4E 3016/4885
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them HPGDS, DPP7, DPEP1 AR 3875/4885ALDH1A1 2161/4885KDM4E 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.